Cite
Commercial genetic testing for type 2 polysaccharide storage myopathy and myofibrillar myopathy does not correspond to a histopathological diagnosis.
MLA
Valberg, Stephanie J., et al. “Commercial Genetic Testing for Type 2 Polysaccharide Storage Myopathy and Myofibrillar Myopathy Does Not Correspond to a Histopathological Diagnosis.” Equine Veterinary Journal, 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1287307429&authtype=sso&custid=ns315887.
APA
Valberg, S. J., Valberg, S. J., Finno, C. J., Henry, M. L., Schott, M., Velez-Irizarry, D., Peng, S., McKenzie, E. C., & Petersen, J. L. (2021). Commercial genetic testing for type 2 polysaccharide storage myopathy and myofibrillar myopathy does not correspond to a histopathological diagnosis. Equine Veterinary Journal.
Chicago
Valberg, Stephanie J, Stephanie J Valberg, Carrie J Finno, Marisa L Henry, Melissa Schott, Deborah Velez-Irizarry, Sichong Peng, Erica C McKenzie, and Jessica L Petersen. 2021. “Commercial Genetic Testing for Type 2 Polysaccharide Storage Myopathy and Myofibrillar Myopathy Does Not Correspond to a Histopathological Diagnosis.” Equine Veterinary Journal. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1287307429&authtype=sso&custid=ns315887.